Vaccination strategy – Page 24 – Communicable Diseases Research

Assessing critical gaps in COVID-19 testing capacity: the case of delayed results in Ecuador

COVID-19 테스트 용량의 심각한 격차 평가: 에콰도르에서 지연된 결과의 경우

Research Article

Published on 2021-04-012022-09-01
Journal: BMC Public Health [Category] MERS, SARS, 진단,

[키워드] Assessing association average clinical care clinically collected contribute country COVID-19 COVID-19 cases COVID-19 testing Critical database death rate death rates Decision making Decision-making diagnostic diagnostic testing Diseases Ecuador Generalized linear model Health policy highest highlight individual inequality Infectious diseases information information management Laboratory limitation management Ministry of Health mitigate National physical processed processing reported resource Result RT-PCR testing Sample subsequent supplementary material Testing Vaccination strategies Vaccination strategy WHO’
[DOI] 10.1186/s12889-021-10715-x PMC 바로가기 [Article Type] Research Article

Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery

임신 중 SARS-CoV-2 감염 후 항체 반응에 대한 종단적 분석: 임신 초기부터 분만까지

Clinical Trial

Published on 2021-04-012022-09-12
Journal: Journal of reproductive immunology [Category] MERS, SARS, 임상, 진단,

Vaccination strategies against COVID-19 and the diffusion of anti-vaccination views

Article

Published on 2021-03-232022-10-29
Journal: Scientific Reports [Category] COVID-19, SARS,

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection

감염 후 6~8개월 후 회복 중인 COVID-19 환자에서 SARS-CoV-2 특이적 B 및 T 세포 반응의 지속성

Article

Published on 2021-03-122022-09-11
Journal: Med (New York, N.Y.) [Category] MERS, SARS, 변종, 임상, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 adaptive Adaptive immune response adaptive immune responses addition anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG Anti-spike antibody B cell binding domain center collected convalescent convalescent COVID-19 patient coronavirus disease Coronavirus disease 2019 Coronavirus-2 Council Course COVID-19 COVID-19 patients COVID-19 research Critical disease declined development Diagnosis disease severity Donor elevated European Horizon IgG immune immune response immune responses Immunity Immunoglobulin immunoglobulin M immunological Immunological memory Infection information Italian Level Longevity longevity of immune response Medicine medium memory B Mild Ministry of Health monitoring National natural infection Neutralizing Neutralizing activity neutralizing antibody onset of symptom patients plasma Protective protective immunity provide remained Research respiratory SARS-CoV-2 serum severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 significantly lower subset supported Swedish symptom onset T cell T cell response T cell responses tested the patient union vaccination Vaccination strategies Vaccination strategy variants virus
[DOI] 10.1016/j.medj.2021.02.001 PMC 바로가기 [Article Type] Article

UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records

Research Article

Published on 2021-03-112022-10-28
Journal: BMC Public Health [Category] COVID-19,

[키워드] Adults age Analysis Asthma burden Cancer children Chronic kidney disease chronic liver disease clinical conditions Confidence intervals COVID-19 death decrease defined described diabete diagnosis of cancer distribution effective Electronic health record Electronic health records estimate group Guidance Health health condition higher risk increases in individual individuals Multimorbidity National Older age Practice Pregnancy Prevalence prevalence study proportion Public health intervention repeated resource Result risk Risk factors secondary care severe COVID-19 stratified supplementary material Support Survivors underlying condition United Kingdom Vaccination strategy Vaccine
[DOI] 10.1186/s12889-021-10427-2 PMC 바로가기 [Article Type] Research Article

A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach

신종 전염병의 맥락에서 T-세포 에피토프 발견 및 백신 설계를 가속화하기 위한 프로테옴 전체 면역정보학 도구: 민족 중심 접근

Immunology

Published on 2021-02-262022-09-11
Journal: Frontiers in Immunology [Category] MERS, 유전자 메커니즘,

[키워드] accelerate Accuracy Analysis AUC build caused CD4+ T-cell CD8+ ChAdOx1 ChAdOx1 vaccine clinical trials comparable complicate Context contribute coronavirus country Coverage COVID-19 pandemic criteria disease distribution effective Emerging infectious disease Emerging infectious diseases emerging-infectious disease Epidemics epitope epitope clusters epitope density epitope discovery epitope mapping Epitope-based vaccine Epitopes Ethnic groups Ethnicity frequencies Frequency genetic polymorphisms geographic distributions glycoprotein HLA HLA allele HLA allele frequencies HLA allele frequency HLA alleles human leukocyte antigen immune response immune responses immune responsiveness immune system immunodominant immunoinformatics in silico Infectious diseases investigated Japanese leukocyte Mortality NetMHCpan optimization Pathogens peptide Phase III clinical trials polymorphism Population predicted protein antigen protein antigens proteome Region retrieved SARS-CoV-2 SARS-CoV-2 spike glycoprotein SARS-like coronavirus spike glycoprotein T-cell T-cell epitope T-cell epitopes the SARS-CoV-2 utility vaccination Vaccination strategy Vaccinations Vaccine vaccine candidates Vaccine design vaccine-induced immune response vaccine-induced immune responses Variability Variation virus
[DOI] 10.3389/fimmu.2021.598778 PMC 바로가기 [Article Type] Immunology

Bacillus Calmette-Guerin (BCG): the adroit vaccine

Review

Published on 2021-02-082022-10-27
Journal: AIMS Microbiology [Category] COVID-19,

[키워드] Activation all-cause mortality approach Bacillus Calmette-Guérin BCG clinical trial correlation COVID-19 COVID-19 pandemic COVID-19 transmission disseminated tuberculosis Effect Effects Efficacy epidemiological Epidemiological study Evidence Fever form H1N1 herpes simplex Heterologous highlight Host HPV human vaccine humans implication Infants influence Influenza virus innate immune memory investigated mechanism mortality rate Neonatal non-specific non-specific effects, vaccine objective offered papilloma protective effect pulmonary tuberculosis reduce Research respiratory syncytial virus Result RSV significantly subject suggested the vaccine thought Tuberculosis vaccination Vaccination strategy Vaccine viral infection viral infections virus while
[DOI] 10.3934/microbiol.2021007 PMC 바로가기 [Article Type] Review

Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea

Article

Published on 2021-02-042022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform

Research

Published on 2020-12-142022-10-27
Journal: BMC Bioinformatics [Category] Coronavirus, COVID-19, Fulltext, MERS,

In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform

Research

Published on 2020-12-142022-10-27
Journal: BMC Bioinformatics [Category] COVID-19,